Companies: 10,795·Total market cap: $144.5T
SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.

SWTXNASDAQHealthcare
$46.99
+$0.01(+0.02%)
Market Cap$3.5B
P/E Ratio
52W High$62
52W Low$28.21
Overview

SpringWorks Therapeutics, Inc.(SWTX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · SWTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.19B$0.01B$0.01B$0.00B$0.04B
Cost of Revenue$0.01B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.18B$0.01B$0.00B($0.00B)$0.03B
Gross Margin %(computed)93.45%92.25%69.16%99.00%
Operating Expenses
R&D Expenses$0.20B$0.15B$0.15B$0.10B$0.05B
G&A Expenses$0.26B$0.20B$0.13B$0.07B$0.03B
Total Operating Expenses$0.46B$0.35B$0.28B$0.17B$0.08B
Operating Income($0.28B)($0.34B)($0.28B)($0.17B)($0.05B)
Operating Margin %(computed)-145.17%-132.35%
Interest Income$0.03B$0.02B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.26B)($0.33B)($0.28B)($0.17B)($0.05B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.26B)($0.33B)($0.28B)($0.17B)($0.05B)
Net Margin %(computed)-134.73%-130.21%
Per Share & EBITDA
EPS (Basic)$-3.48$-5.15$-5.21$-3.59$-1.05
Wtd Avg Shares0.07B0.06B0.05B0.05B0.04B
EBITDA($0.27B)($0.34B)($0.28B)($0.17B)($0.05B)
EBITDA Margin %(computed)-143.36%-131.36%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解SpringWorks Therapeutics, Inc.

关于SpringWorks Therapeutics, Inc.(SWTX)损益表

SpringWorks Therapeutics, Inc.(SWTX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,SWTX实现营收$0.19B,毛利润$0.18B(毛利率93.45%),净利润($0.26B)(净利率-134.73%)。

常见问题

SWTX · 4 问

SpringWorks Therapeutics, Inc.(SWTX)2024财年营收为$0.19B,同比up3417.3%。

SWTX revenueSWTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09